Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.46 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | LAP3 | P28838 | 3/20 | 0.44 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7130634 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL3451868 | 1.00 | ALDH1A1 (0.59) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Hydrochloric Acid SCHEMBL23833941 | 0.98 | ALDH1A1 (0.57) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Hydrochloric Acid SCHEMBL23833944 | 0.98 | ALDH1A1 (0.57) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL29233119 | 0.90 | ALDH1A1 (0.50) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Monoethanolamine SCHEMBL28349826 | 0.89 | ALDH1A1 (0.49) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL1527332 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL1527333 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL2121537 | 0.82 | MAPT (0.60) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL7563707 | 0.82 | ALDH1A1 (0.57) | ALDH1A1MEN1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115304516-A | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2022-11-08 | — | — | CN | claimed |
| CN-101601634-B | Infant anus skin care solution | ZHANG JIEYU | 2012-07-18 | — | — | CN | claimed |
| CN-101601634-A | Infant anus skin care solution | YULIN ZHANG (CN) | 2009-12-16 | — | — | CN | claimed |
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | claimed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | claimed |
| CN-119667035-A | Method for rapidly detecting chiral substances in white spirit and fermented grains and application | 宜宾五粮液股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| CN-115304516-B | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | disclosed |
| WO-2023125182-A1 | PROPIONIC ACID DERIVATIVE AND MEDICAL USE THEREOF | 海思科医药集团股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| EP-0392619-B1 | Malodors reduction | QUEST INT (NL) | 1995-06-21 | — | — | EP | disclosed |
| EP-0647449-A1 | Sustained-release preparation of anti-endothelin substance | Takeda Chemical Industries, Ltd. (JP) | 1995-04-12 | — | — | EP | disclosed |
| EP-0626174-A2 | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| EP-0552417-A1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-5204023-A | Trapping with reaction product(Schiff base) of desirable aldehyde and amine; soaps, detergents, foods | UNILEVER PATENT HOLDINGS B.V. (NL) | 1993-04-20 | — | — | US | disclosed |
| EP-0528312-A2 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-24 | — | — | EP | disclosed |
| EP-0392619-A2 | Malodors reduction | QUEST INTERNATIONAL B.V. (NL) | 1990-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | CASP4, CASP3, CASP14 | ALDH1A1 2333/4885MEN1 2743/4885LMNA 3451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.